Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cognitive impairment among different clinical courses of multiple sclerosis.
Evoked potentials in multiple sclerosis.
Impact of simulated microgravity on oligodendrocyte development: implications for central nervous system repair.
Update on multiple sclerosis treatments.
Treatment with interferon-beta does not induce anti-nuclear and anti-neuronal serum autoantibodies in multiple sclerosis patients.
Teriflunomide for oral therapy in multiple sclerosis.
Anti-interleukin-2 receptor alpha for multiple sclerosis?
Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis.
TRPV1 Gates Tissue Access and Sustains Pathogenicity in Autoimmune Encephalitis.
Isolation & characterization of Bartonella sp. from optic neuritis patients.
Central Veins in Brain Lesions Visualized With High-Field Magnetic Resonance Imaging: A Pathologically Specific Diagnostic Biomarker for Inflammatory Demyelination in the Brain.
The potential of microRNAs as biofluid markers of neurodegenerative diseases - a systematic review.
An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device.
Current and emerging therapies in multiple sclerosis: a systematic review.
[Amino acids content in the blood serum of patients with multiple sclerosis.]
Tetracyclines inhibit human synovial collagenase in vivo and in vitro.
Neurological deficits caused by tissue hypoxia in neuroinflammatory disease.
Monitoring neuromyelitis optica activity.
A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis.
Effects of propentofylline on CNS remyelination in the rat brainstem.
Unmet care needs of people with a neurological chronic disease: a cross-sectional study in Italy on Multiple Sclerosis.
Brain Plasticity Effects of Neuromodulation Against Multiple Sclerosis Fatigue.
Possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection.
From genes to characteristics of multiple sclerosis.
Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE.

Pages